Associated Papers
Genome Instability and Somatic Mutagenesis in Autoimmune Diseases.
Vijayraghavan S et al.
Cancers, 2026
Disease Trajectories and Glucocorticoid Exposure in VEXAS Syndrome Treated with Cytokine-Directed Therapies.
Turturice BA et al.
Annals of the Rheumatic Diseases, 2026
Hypomethylating agents in vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS): A systematic review.
Hoff FW et al.
British Journal of Haematology, 2026
VEXAS syndrome: a comprehensive review of pathogenesis, clinical spectrum, and therapeutic strategies.
Groarke EM et al.
Lancet (london, England), 2026
Decoding VEXAS syndrome: emerging insights into pathogenesis and clinical management.
Fiumara M et al.
Current Opinion in Rheumatology, 2026
Mapping VEXAS-associated and rare UBA1 variants in the United Kingdom: Insights from patient cohorts and the general population.
Martinez Rodriguez A et al.
British Journal of Haematology, 2026
Clinical Manifestations of VEXAS Syndrome Across a Broad Spectrum of UBA1 Mutation Burden.
Anderson M et al.
Arthritis & Rheumatology (hoboken, N.j.), 2026
Distinct characteristics of VEXAS-causative UBA1 M41 and recurrent functional non-M41 mutations.
Sakuma M et al.
Leukemia, 2025
Primary CD34+ cells of patients with vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome are highly sensitive to targeted treatment with TAK-243.
Nowak D et al.
British Journal of Haematology, 2025
UBA1-depleted neutrophils disrupt immune homeostasis and induce VEXAS-like autoinflammatory disease in mice.
Dong G et al.
The Journal of Clinical Investigation, 2025
Characterizing VEXAS syndrome in women: Findings from an international multicenter study.
Bourguiba R et al.
Journal of Internal Medicine, 2025
Coexistence of VEXAS Syndrome and Chronic Hepatitis B Virus Infection: a Case Report and Literature Review.
Lin K et al.
Clinical Reviews in Allergy & Immunology, 2025
Developing efficient predictive models for the diagnosis of VEXAS syndrome.
Montes D et al.
Seminars in Arthritis and Rheumatism, 2025
VEXAS syndrome and immune-mediated rheumatic diseases: overlaps in clinical features and mechanisms.
Kaul A et al.
The Lancet. Rheumatology, 2025
Novel Insights into the Clinical Features, Genetic Spectrum and Clonal Evolution of Patients Carrying NLRP3 Mosaicism.
Bonet N et al.
Journal of Clinical Immunology, 2025
Emerging insights into mosaic errors of immunity.
Roosens W et al.
Trends in Immunology, 2025
Rapid clinical deployment of UBA1 testing in patients with VEXAS syndrome.
Wadsworth PA et al.
American Journal of Clinical Pathology, 2025
VEXAS syndrome caused by a UBA1 mutation is complicated by recurrent infections leading to hemophagocytic lymphohistiocytosis.
Tang Y et al.
Genes & Diseases, 2025
Prevalence and outcome of VEXAS syndrome in unrelated hematopoietic cell transplantation for bone marrow failure.
Zaimoku Y et al.
Clinical and Experimental Medicine, 2025
Ocular Features of VEXAS Syndrome: A Systematic Review and Meta-analysis.
Quigley C et al.
American Journal of Ophthalmology, 2025
VEXAS syndrome with eosinophilia and pathologically mimicking histiocytosis: a case report.
Murai Y et al.
Modern Rheumatology Case Reports, 2025
Clonal hematopoiesis meets an autoinflammatory disease: the new paradigm of VEXAS syndrome.
Fiumara M et al.
Expert Review of Hematology, 2025
Kidney involvement in VEXAS syndrome: insights from a rare case of secondary amyloidosis and systematic review of renal biopsy-confirmed reports.
Ştefan G et al.
Clinical Rheumatology, 2025
Low remission rates and high incidence of adverse events in a prospective VEXAS syndrome registry.
Kirino Y et al.
Rheumatology (oxford, England), 2025
VEXAS syndrome through a rheumatologist's lens: insights from a Spanish national cohort.
García-Escudero P et al.
Rheumatology (oxford, England), 2025
Therapeutic Challenges in the Management of VEXAS Syndrome: A Case Report.
Kelly G et al.
The Australasian Journal of Dermatology, 2025
Mechanisms of hematopoietic clonal dominance in VEXAS syndrome.
Molteni R et al.
Nature Medicine, 2025
Rapid Screening and Monitoring of UBA1 Mutations in VEXAS Syndrome.
Martín Castillo I et al.
The Journal of Molecular Diagnostics : Jmd, 2025
VEXAS syndrome: A newly identified X-Linked hematoinflammatory disorder - A comprehensive overview of its genetic, molecular, inflammatory, and clinical landscape.
Singh A et al.
Journal of Autoimmunity, 2025
In depth transcriptomic profiling defines a landscape of dysfunctional immune responses in patients with VEXAS syndrome.
Mizumaki H et al.
Nature Communications, 2025
Altered IgG4 serum levels in VEXAS syndrome - a retrospective monocentric cohort study.
Saur SJ et al.
Rheumatology International, 2025
VEXAS syndrome with p.Met41Leu UBA1 gene mutation misdiagnosed as tumid lupus: A series of 3 cases.
Mizes A et al.
Jaad Case Reports, 2025
[VEXAS- NEWLY REPORTED SYNDROME WITH OCULAR MANIFESTATIONS: CASE REPORT].
Abumanhal M et al.
Harefuah, 2025
Treatment experiences with focus on IL-6R inhibition in patients with VEXAS syndrome and a case of remission with azacytidine treatment.
Johansen MM et al.
Rheumatology (oxford, England), 2025
Neurological manifestations in patients with VEXAS syndrome.
Bert-Marcaz C et al.
Journal of Neurology, 2025
Novel use of Siltuximab in a patient with VEXAS Syndrome.
Cáceres-Nazario B et al.
Annals of Hematology, 2025
VEXAS Syndrome: Histiocytoid Cells With Feathery Cytoplasm as a Clue to the Diagnosis.
Ko CJ et al.
Journal of Cutaneous Pathology, 2025
Concurrent inhibited erythropoiesis in a case of VEXAS syndrome.
Xing L et al.
Annals of Hematology, 2025
Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, and Somatic (VEXAS) Syndrome: A Diagnostic and Therapeutic Conundrum.
Miranda S et al.
Cureus, 2025
Utilizing C. elegans Spermatogenesis and Fertilization Mutants as a Model for Human Disease.
Perez SM et al.
Journal of Developmental Biology, 2025
A Japanese case of VEXAS syndrome after COVID-19 vaccination: Comparison with previously reported cases.
Miyagi Y et al.
Modern Rheumatology Case Reports, 2025
VEXAS syndrome: an adult-onset autoinflammatory disorder with underlying somatic mutation.
Kötter I et al.
Current Opinion in Rheumatology, 2025
Methodology and clinical utility of longitudinal UBA1 tracking in VEXAS syndrome.
Gurnari C et al.
British Journal of Haematology, 2025
VEXAS syndrome: is it more a matter of inflammation or hematopoietic clonality? A case series approach to diagnosis, therapeutic strategies and transplant management.
Costa A et al.
Annals of Hematology, 2025
Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA network.
Vitale A et al.
Frontiers in Pharmacology, 2025
Vexas Syndrome in a Moroccan Patient: The Story of a Two-Year Diagnostic Lag.
Allaoui A et al.
European Journal of Case Reports in Internal Medicine, 2025